In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Sodium liothyronine Drug Master File in Korea (Sodium liothyronine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sodium liothyronine. The MFDS reviews the Sodium liothyronine KDMF as part of the drug registration process and uses the information provided in the Sodium liothyronine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Sodium liothyronine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sodium liothyronine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Sodium liothyronine suppliers with KDMF on PharmaCompass.